Literature DB >> 31773290

Molecular Diagnostic Advances in Transplant Infectious Diseases.

Brittany A Young1,2, Kimberly E Hanson1,2,3, Carlos A Gomez4,5.   

Abstract

PURPOSE OF REVIEW: The infectious complications of transplantation can have devastating consequences for patients. Early and accurate diagnosis is essential to good outcomes. This review describes recent advances in pathogen-directed diagnostic testing and discusses the role of new methods for transplant infectious diseases. RECENT
FINDINGS: Several molecular assays have been introduced into clinical practice in recent years. When the results of rapid testing are linked to patient-specific interventions, improved outcomes can be realized. Syndromic testing along with metagenomic next-generation sequencing (mNGS) represents novel approaches to infection diagnosis. However, the optimal use of these tests for transplant patients along with an overall assessment of cost-effectiveness demands further study. Molecular diagnostics are revolutionizing transplant care. Clinicians need to be aware of the current diagnostic landscape and have a working knowledge of the nuances related to test performance, result interpretation, and cost.

Entities:  

Keywords:  Immunocompromised host; Molecular testing; PCR-based assays; Syndromic testing; Transplant infections, metagenomic next-generation sequencing (mNGS)

Year:  2019        PMID: 31773290     DOI: 10.1007/s11908-019-0704-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  119 in total

1.  Performance of the Verigene® enteric pathogens test, Biofire FilmArray™ gastrointestinal panel and Luminex xTAG® gastrointestinal pathogen panel for detection of common enteric pathogens.

Authors:  Richard S P Huang; Coreen L Johnson; Lauryn Pritchard; Richard Hepler; Trang T Ton; James J Dunn
Journal:  Diagn Microbiol Infect Dis       Date:  2016-09-22       Impact factor: 2.803

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.

Authors:  Eleftherios Mylonakis; Cornelius J Clancy; Luis Ostrosky-Zeichner; Kevin W Garey; George J Alangaden; Jose A Vazquez; Jeffrey S Groeger; Marc A Judson; Yuka-Marie Vinagre; Stephen O Heard; Fainareti N Zervou; Ioannis M Zacharioudakis; Dimitrios P Kontoyiannis; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2015-01-12       Impact factor: 9.079

4.  Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.

Authors:  David S Perlin; Nathan P Wiederhold
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

5.  Noninvasive monitoring of infection and rejection after lung transplantation.

Authors:  Iwijn De Vlaminck; Lance Martin; Michael Kertesz; Kapil Patel; Mark Kowarsky; Calvin Strehl; Garrett Cohen; Helen Luikart; Norma F Neff; Jennifer Okamoto; Mark R Nicolls; David Cornfield; David Weill; Hannah Valantine; Kiran K Khush; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

Review 6.  Advances in Rapid Molecular Blood Culture Diagnostics: Healthcare Impact, Laboratory Implications, and Multiplex Technologies.

Authors:  Rosemary C She; Jeffrey M Bender
Journal:  J Appl Lab Med       Date:  2018-11-21

7.  T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood.

Authors:  Giulia De Angelis; Brunella Posteraro; Elena De Carolis; Giulia Menchinelli; Francesco Franceschi; Mario Tumbarello; Gennaro De Pascale; Teresa Spanu; Maurizio Sanguinetti
Journal:  J Antimicrob Chemother       Date:  2018-03-01       Impact factor: 5.790

8.  Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.

Authors:  T Boch; M Reinwald; P Postina; O A Cornely; J J Vehreschild; C P Heußel; W J Heinz; M Hoenigl; S Eigl; T Lehrnbecher; J Hahn; B Claus; M Lauten; G Egerer; M C Müller; S Will; N Merker; W-K Hofmann; D Buchheidt; B Spiess
Journal:  Mycoses       Date:  2015-10-26       Impact factor: 4.377

Review 9.  Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis.

Authors:  Stephanie S Buehler; Bereneice Madison; Susan R Snyder; James H Derzon; Nancy E Cornish; Michael A Saubolle; Alice S Weissfeld; Melvin P Weinstein; Edward B Liebow; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

10.  Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults.

Authors:  Charles Langelier; Katrina L Kalantar; Farzad Moazed; Michael R Wilson; Emily D Crawford; Thomas Deiss; Annika Belzer; Samaneh Bolourchi; Saharai Caldera; Monica Fung; Alejandra Jauregui; Katherine Malcolm; Amy Lyden; Lillian Khan; Kathryn Vessel; Jenai Quan; Matt Zinter; Charles Y Chiu; Eric D Chow; Jenny Wilson; Steve Miller; Michael A Matthay; Katherine S Pollard; Stephanie Christenson; Carolyn S Calfee; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-27       Impact factor: 11.205

View more
  2 in total

Review 1.  Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.

Authors:  Paul J Maglione
Journal:  Immunol Allergy Clin North Am       Date:  2020-06-09       Impact factor: 3.479

Review 2.  Emerging Options for the Diagnosis of Bacterial Infections and the Characterization of Antimicrobial Resistance.

Authors:  Simone Rentschler; Lars Kaiser; Hans-Peter Deigner
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.